Cambridge Healthtech Institute’s 6th Annual
AI/Machine Learning for Early Drug Discovery – Part 1
AI-Driven Decision-Making for Drug Design, Screening, and Lead Optimization
APRIL 2 - 3, 2024
Artificial Intelligence (AI)/Machine Learning (ML) for Early Drug Discovery is a two-part conference that brings together a diverse group of experts from chemistry, target discovery, pharmacology, and bioinformatics to talk about the increasing use of computational tools, models, algorithms, and data analytics for drug development. The talks will highlight the pros and cons of AI/ML-driven decision-making using relevant case studies from small molecule and peptide drug development. The first part of the conference will focus on how AI/ML can help improve drug design, hit identification, and lead optimization.
6:00 pm MONDAY, APRIL 1: Dinner Short Course*
SC3: Fundamentals of Generative AI for Drug Discovery
*Premium Pricing or separate registration required. See Short Courses page for details.